tiprankstipranks
Trending News
More News >
Tokuyama Corporation (JP:4043)
:4043

Tokuyama (4043) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4043

Tokuyama

(4043)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 5.2)
Rating:63Neutral
Price Target:
¥4,300.00
▲(2.67% Upside)
The score is supported primarily by solid financial performance (improving margins, strong equity base, and higher free cash flow) and reasonable valuation (low-teens P/E and a 2.5% dividend). These positives are offset by weak technicals, with the stock trading below key short-term moving averages and low RSI signaling soft near-term momentum.
Positive Factors
Margin Improvement
Sustained improvement in gross and net margins indicates stronger cost control and pricing power across segments. Higher margins improve resilience to input cost shocks, support reinvestment in specialty products, and underpin longer-term margin sustainability even if volumes fluctuate.
Strong Balance Sheet
Low leverage and a high equity ratio provide financial flexibility for capital-intensive chemical and cement operations. A solid balance sheet reduces refinancing risk, enables steady capex and strategic investments, and cushions cyclical downturns, supporting durable operations.
Free Cash Flow Generation
Material FCF growth and healthy conversion of net income to cash enhance the company's ability to fund dividends, maintenance capex and selective investments without adding leverage. Reliable cash generation improves long-term financial resilience and strategic optionality.
Negative Factors
Limited Revenue Growth
Near-flat top-line expansion signals constrained demand or limited market share gains in core segments. Without stronger revenue growth, earnings upside must come from margins or cost cuts, limiting scalability and making long-term EPS growth more dependent on efficiency than market expansion.
Operating Cash Flow Variability
A decline in operating cash conversion points to variability in working capital or cyclical cash swings. Persistent OCF volatility can strain funding for capex and dividends during downturns, undermining the predictability of free cash flow for strategic investments.
Exposure to Energy & Feedstock Costs
Tokuyama's energy-intensive chemical and cement businesses are structurally exposed to volatile feedstock and electricity costs. Sustained input-price inflation or price pass-through delays can compress margins and increase earnings cyclicality over the medium term.

Tokuyama (4043) vs. iShares MSCI Japan ETF (EWJ)

Tokuyama Business Overview & Revenue Model

Company DescriptionTokuyama Corporation produces and sells various chemical products in Japan. The company operates through six segments: Chemicals, Cement, Electronics Materials, Life Science, Eco Business, and Others. The Chemicals segment offers caustic soda, soda ash, calcium chloride, sodium silicate, vinyl chloride monomer, polyvinyl chloride resin, propylene oxide, chlorinated solvents, and hydrogen. The Cement segment provides cement, ready-mixed concrete, and cement-type stabilizer, as well as engages in the resource recycling business. The Electronic Materials segment provides polycrystalline silicon; fumed silica and tetrachlorosilane; aluminum nitride; high-purity chemicals for electronics manufacturing and photoresist developer; and isopropyl alcohol. The Life Science segment provides medical diagnosis systems, dental materials and equipment, pharmaceutical ingredients and intermediates, plastic lens-related materials for glasses, and microporous film. The Eco Business segment offers plastic window sashes, ion exchange membranes, as well as engages in waste gypsum board recycling activity. The company was formerly known as Tokuyama Soda Co., Ltd. and changed its name to Tokuyama Corporation in April 1994. Tokuyama Corporation was incorporated in 1918 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyTokuyama generates revenue through multiple streams, primarily from the sale of its chemical products and materials. Key revenue streams include the semiconductor materials division, which supplies silicon wafers and other related products; the pharmaceutical sector, which focuses on active pharmaceutical ingredients; and construction materials, which includes cement and other construction-related chemicals. The company also benefits from strategic partnerships with various technology firms and suppliers, enabling it to expand its market reach and enhance product development. Additionally, Tokuyama's commitment to research and development allows it to innovate and introduce new products, contributing to increased sales and market share.

Tokuyama Financial Statement Overview

Summary
Solid fundamentals: improving profitability (gross margin 31.52%, net margin 6.82%) and stable leverage (debt-to-equity 0.42, equity ratio 54.94%). Revenue growth is modest (0.32%) and cash-flow quality is generally strong (FCF +22.83%) with some operating cash flow variability.
Income Statement
75
Positive
Tokuyama's revenue showed a modest increase from 2024 to 2025, with a revenue growth rate of 0.32%. The gross profit margin improved to 31.52% in 2025, reflecting efficient cost management. The net profit margin increased to 6.82%, indicating enhanced profitability. The EBIT margin was 8.74%, and the EBITDA margin was 15.13%, both showing positive trends. Overall, the company demonstrates strong profitability with stable revenue growth.
Balance Sheet
70
Positive
The debt-to-equity ratio improved from 0.42 in 2024 to 0.42 in 2025, showing consistent leverage management. The return on equity (ROE) increased to 8.94%, indicating effective use of equity to generate profit. The equity ratio was 54.94%, reflecting a strong equity base. Overall, Tokuyama maintains a solid balance sheet with stable leverage and equity management.
Cash Flow
65
Positive
Tokuyama's free cash flow grew by 22.83%, showcasing strong cash-generating abilities. However, the operating cash flow to net income ratio decreased to 2.24, while the free cash flow to net income ratio remained stable at 1.27, indicating effective conversion of net income to cash flow. Overall, the cash flow statements reflect robust cash management, albeit with some variability in operating cash flow.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue342.38B343.07B341.99B351.79B293.83B302.41B
Gross Profit109.27B108.14B99.52B90.78B95.41B95.15B
EBITDA49.39B51.91B44.88B36.79B48.75B49.49B
Net Income20.90B23.39B17.75B9.36B28.00B24.53B
Balance Sheet
Total Assets474.44B476.21B457.36B478.34B433.21B386.79B
Cash, Cash Equivalents and Short-Term Investments79.84B75.54B48.68B68.08B83.12B83.68B
Total Debt113.15B110.69B105.78B142.45B109.22B98.44B
Total Liabilities197.73B202.35B197.41B236.74B200.29B181.53B
Stockholders Equity262.17B261.56B249.25B229.45B224.50B198.56B
Cash Flow
Free Cash Flow0.0029.77B24.24B-43.72B-5.90B19.51B
Operating Cash Flow0.0052.37B55.83B-11.80B25.99B43.31B
Investing Cash Flow0.00-23.48B-30.41B-33.76B-33.80B-19.28B
Financing Cash Flow0.00-1.11B-46.51B30.15B5.12B-22.53B

Tokuyama Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4188.00
Price Trends
50DMA
4176.62
Negative
100DMA
3949.38
Positive
200DMA
3459.21
Positive
Market Momentum
MACD
55.18
Positive
RSI
36.41
Neutral
STOCH
43.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4043, the sentiment is Negative. The current price of 4188 is below the 20-day moving average (MA) of 4325.25, above the 50-day MA of 4176.62, and above the 200-day MA of 3459.21, indicating a neutral trend. The MACD of 55.18 indicates Positive momentum. The RSI at 36.41 is Neutral, neither overbought nor oversold. The STOCH value of 43.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4043.

Tokuyama Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥360.35B10.719.65%3.91%0.87%16.71%
75
Outperform
¥292.30B23.151.00%-3.06%45.21%
74
Outperform
¥296.02B11.225.47%3.41%2.60%9.50%
63
Neutral
¥290.54B11.468.86%2.65%-0.04%3.15%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
¥260.72B45.141.47%4.29%-7.45%-71.68%
55
Neutral
¥594.20B-80.57-1.15%3.49%-6.83%-123.67%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4043
Tokuyama
4,038.00
1,519.13
60.31%
JP:4118
Kaneka
4,681.00
1,136.51
32.06%
JP:4182
Mitsubishi Gas Chemical Company
3,063.00
529.07
20.88%
JP:4208
UBE Industries
2,671.00
556.52
26.32%
JP:4205
Zeon
1,886.50
471.35
33.31%
JP:4046
OSAKA SODA CO.,LTD.
2,244.00
629.90
39.02%

Tokuyama Corporate Events

Tokuyama Cuts FY2025 Earnings Forecast on Weak Chemical Pricing
Jan 30, 2026

Tokuyama Corporation has lowered its full-year forecast for fiscal 2025, cutting projected net sales from ¥364.5 billion to ¥351.5 billion and reducing expected operating and ordinary profit from ¥41.5 billion to ¥39.0 billion, with profit attributable to owners of the parent revised down from ¥29.0 billion to ¥27.5 billion. The company attributed the downgrade primarily to weaker-than-expected performance through the third quarter, citing declines in domestic and overseas selling prices of chemical products, a development that signals continued pricing pressure in its core markets and a more challenging earnings environment despite profits still expected to exceed fiscal 2024 levels.

The most recent analyst rating on (JP:4043) stock is a Buy with a Yen4989.00 price target. To see the full list of analyst forecasts on Tokuyama stock, see the JP:4043 Stock Forecast page.

Tokuyama Lifts Operating Profit but Cuts Forecast on Weak Vinyl Chloride Markets
Jan 30, 2026

Tokuyama reported that while the consolidation of the Tokuyama Life Science Group and solid demand for semiconductor-related products supported revenue, overall net sales declined year on year due to worsening overseas market conditions for vinyl chloride-related products. Operating profit increased compared with the previous year, driven by firm semiconductor-related sales and manufacturing cost improvements, but based on results through the third quarter of fiscal 2025, the company revised its full-year performance forecast downward, signaling a more cautious earnings outlook for stakeholders.

The most recent analyst rating on (JP:4043) stock is a Buy with a Yen4989.00 price target. To see the full list of analyst forecasts on Tokuyama stock, see the JP:4043 Stock Forecast page.

Tokuyama Lifts Profit Outlook and Dividends on Strong Q3, Expands Life-Science Footprint
Jan 30, 2026

Tokuyama reported third-quarter fiscal 2025 consolidated results showing essentially flat net sales at ¥251.5 billion but a strong improvement in profitability, with operating profit up 26.9% to ¥26.7 billion and profit attributable to owners of parent rising 11.5% to ¥18.9 billion, alongside a jump in comprehensive income and an increase in total assets and shareholders’ equity. The company maintained an aggressive shareholder return stance by raising annual dividend guidance to ¥120 per share from ¥100 in the previous year and announced an upward revision to its full-year fiscal 2025 forecast, now expecting modest sales growth but around 30% gains in operating and ordinary profit and a 17.6% increase in full-year net profit, while expanding its consolidation scope to include seven new life-science-related subsidiaries, a move that signals strategic reinforcement of its medical and biotech portfolio and potentially strengthens its long-term earnings base and industry positioning.

The most recent analyst rating on (JP:4043) stock is a Buy with a Yen4989.00 price target. To see the full list of analyst forecasts on Tokuyama stock, see the JP:4043 Stock Forecast page.

Tokuyama Reshapes Top Management, Elevates Eco-Business Leader as New President
Jan 23, 2026

Tokuyama Corporation has announced a leadership reshuffle effective April 1, 2026, as part of the introduction of a new management structure. Current President and Executive Officer Hiroshi Yokota will become Representative Director, Chairman and Executive Officer, while Director and Managing Executive Officer Tomohiro Inoue will be promoted to Representative Director, President and Executive Officer, and Fumiaki Iwasaki will step down from his role as Representative Director while remaining a Director and Senior Managing Executive Officer. Inoue’s appointment reflects a steady internal promotion path through key roles in eco business, cement operations, sustainability, carbon-neutral strategy, and new business development, signaling the company’s intent to further strengthen its strategic focus on environmental solutions, corporate planning, and advanced technology commercialization under the new regime.

The most recent analyst rating on (JP:4043) stock is a Buy with a Yen4910.00 price target. To see the full list of analyst forecasts on Tokuyama stock, see the JP:4043 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 31, 2026